| Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection N Afdhal, S Zeuzem, P Kwo, M Chojkier, N Gitlin, M Puoti, ... New England Journal of Medicine 370 (20), 1889-1898, 2014 | 2171 | 2014 |
| Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection N Afdhal, KR Reddy, DR Nelson, E Lawitz, SC Gordon, E Schiff, ... New England Journal of Medicine 370 (16), 1483-1493, 2014 | 1722 | 2014 |
| ACG clinical guideline: evaluation of abnormal liver chemistries PY Kwo, SM Cohen, JK Lim Official journal of the American College of Gastroenterology| ACG 112 (1), 18-35, 2017 | 1152 | 2017 |
| Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus AJ Thompson, AJ Muir, MS Sulkowski, D Ge, J Fellay, KV Shianna, ... Gastroenterology 139 (1), 120-129. e18, 2010 | 974 | 2010 |
| Ledipasvir and sofosbuvir plus ribavirin for treatment of HCV infection in patients with advanced liver disease M Charlton, GT Everson, SL Flamm, P Kumar, C Landis, RS Brown Jr, ... Gastroenterology 149 (3), 649-659, 2015 | 963 | 2015 |
| Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection … PY Kwo, EJ Lawitz, J McCone, ER Schiff, JM Vierling, D Pound, MN Davis, ... The Lancet 376 (9742), 705-716, 2010 | 858 | 2010 |
| Stereotactic body radiotherapy for primary hepatocellular carcinoma DL Andolino, CS Johnson, M Maluccio, P Kwo, AJ Tector, J Zook, ... International Journal of Radiation Oncology* Biology* Physics 81 (4), e447-e453, 2011 | 507 | 2011 |
| Glecaprevir–pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection S Zeuzem, GR Foster, S Wang, A Asatryan, E Gane, JJ Feld, T Asselah, ... New England Journal of Medicine 378 (4), 354-369, 2018 | 501 | 2018 |
| An interferon-free antiviral regimen for HCV after liver transplantation PY Kwo, PS Mantry, E Coakley, HS Te, HE Vargas, R Brown Jr, F Gordon, ... New England Journal of Medicine 371 (25), 2375-2382, 2014 | 486 | 2014 |
| The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States GG Schlauder, GJ Dawson, JC Erker, PY Kwo, MF Knigge, DL Smalley, ... Journal of general virology 79 (3), 447-456, 1998 | 428 | 1998 |
| Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation M Charlton, E Gane, MP Manns, RS Brown Jr, MP Curry, PY Kwo, ... Gastroenterology 148 (1), 108-117, 2015 | 414 | 2015 |
| Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy R Rerknimitr, S Sherman, EL Fogel, C Kalayci, L Lumeng, N Chalasani, ... Gastrointestinal endoscopy 55 (2), 224-231, 2002 | 409 | 2002 |
| Peginterferon alfa‐2b and weight‐based or flat‐dose ribavirin in chronic hepatitis C patients: a randomized trial IM Jacobson, RS Brown Jr, B Freilich, N Afdhal, PY Kwo, J Santoro, ... Hepatology 46 (4), 971-981, 2007 | 390 | 2007 |
| A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis NC Boetticher, CJ Peine, P Kwo, GA Abrams, T Patel, B Aqel, L Boardman, ... Gastroenterology 135 (6), 1953-1960, 2008 | 381 | 2008 |
| Predictors of large esophageal varices in patients with cirrhosis N Chalasani, TF Imperiale, A Ismail, G Sood, M Carey, MC Wilcox, ... Official journal of the American College of Gastroenterology| ACG 94 (11 …, 1999 | 379 | 1999 |
| Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis PY Kwo, F Poordad, A Asatryan, S Wang, DL Wyles, T Hassanein, ... Journal of hepatology 67 (2), 263-271, 2017 | 359 | 2017 |
| Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma HR Cárdenes, TR Price, SM Perkins, M Maluccio, P Kwo, TE Breen, ... Clinical and Translational Oncology 12, 218-225, 2010 | 357 | 2010 |
| Position statement: nonanesthesiologist administration of propofol for GI endoscopy JJ Vargo, LB Cohen, DK Rex, PY Kwo Hepatology 50 (6), 1683-1689, 2009 | 338 | 2009 |
| Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1 KV Kowdley, E Lawitz, F Poordad, DE Cohen, DR Nelson, S Zeuzem, ... New England Journal of Medicine 370 (3), 222-232, 2014 | 333 | 2014 |
| Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1 TD Boyer, AJ Sanyal, F Wong, RT Frederick, JR Lake, JG O’Leary, ... Gastroenterology 150 (7), 1579-1589. e2, 2016 | 327 | 2016 |
